<DOC>
	<DOCNO>NCT00177190</DOCNO>
	<brief_summary>This vitro evaluation cutaneous T-cell lymphoma use patient ' blood tissue evaluate immune response relate identified tumor population dendritic/CD 8 cell .</brief_summary>
	<brief_title>In Vitro Evaluation Immune Responses Cutaneous T-Cell Lymphoma ( CTCL )</brief_title>
	<detailed_description>This vitro evaluation cutaneous T-cell lymphoma use patient blood tissue evaluate immune response relate identified tumor population dendritic/ CD 8 cell follow objective : - Objective I : Evaluate feasibility preparation dendritic cell ( DCs ) , CD8 Sezary cell ( CD4 positive ) vitro , obtain buffy coat skin biopsy area tumor involvement subject cutaneous t-cell lymphoma ( CTCL ) Sezary syndrome ( leukemic stage CTCL ) undergo approve FDA therapy , extracorporeal photopheresis ( ECP ) . - Objective II : Evaluate antigen load DCs . - Objective III : Test functional capacity DCs derive CTCL subject overcome immune tolerance tumor cell ex-vivo , use modify Elispot assay conjunction Granzyme B Elispot assay measurement cytotoxicity .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<criteria>Males female &lt; 18 year age Histologically confirm stage IV cutaneous Tcell lymphoma , least 5 % peripheral blood lymphocyte show atypical morphology consistent Sezary cell Ambulatory stable medical condition Biopsy positive mycosis fungoides/CTCL clonal type CTCL determine PCR TCR Southern blot TCR Received chemotherapy radiotherapy within 4 week prior enrollment Significant psychiatric illness would prevent adequate inform consent opinion principal investigator Systemic steroid therapy maintenance adrenal suppression Known coagulopathy non SS subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cutaneous T-cell Lymphoma</keyword>
	<keyword>Sezary Syndrome</keyword>
	<keyword>Mycosis Fungoides</keyword>
	<keyword>Immune Responses</keyword>
</DOC>